The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
g-Rate–based machine learning model to predict overall survival (OS) in patients with metastatic prostate cancer (mPC) while on treatment.
 
Harshraj Leuva
Consulting or Advisory Role - Seattle Genetics/Astellas
 
Jieqiong Wang
No Relationships to Disclose
 
Mohamed Azzam
No Relationships to Disclose
 
Mengxi Zhou
No Relationships to Disclose
 
Benjamin Teply
Consulting or Advisory Role - Exelixis; Pfizer/NCCN
Research Funding - Bellicum Pharmaceuticals (Inst); Bristol-Myers Squibb (Inst); Seagen (Inst)
 
Raymond Bergan
Research Funding - Taproot Health Inc (Inst)
Patents, Royalties, Other Intellectual Property - I hold several patents, and currently have two pending, related to small molecule therapeutics that inhibit cancer cell motility, bone destruction and screening assays for potentially active drugs.
Other Relationship - Hebei Cancer Hospital
 
Susan Bates
Honoraria - Merck (I)
Consulting or Advisory Role - Akita Biomedical (I); ElmediX; OnKure; PEGASCY; SERVIER
Research Funding - Amgen (Inst); Ipsen (Inst); Merck (Inst); Pfizer; RenovoRx (Inst)
 
Antonio Fojo
Honoraria - Merck
Consulting or Advisory Role - Akita Biomedical
Research Funding - Ipsen (Inst); Merck (Inst); Pfizer (I); Pfizer (Inst)